ANDA 75558, held by Hospira. Vecuronium Bromide.
As of Nov 15, 2026, ANDA 75558 (Vecuronium Bromide), held by Hospira, was first approved by FDA on Sep 11, 2001, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 11, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Vecuronium Bromide4MG/VIAL ยท injectable;injection | Vecuronium Bromide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
